Pages that link to "Q43597084"

The following pages link to Optimal design of a population pharmacodynamic experiment for ivabradine (Q43597084):

Displaying 21 items.

• Commentary on Dartois et al.--model building in population PK-PD analyses. A 2002-2004 literature survey (Q28755933) (← links)
• A model-based meta-analysis of monoclonal antibody pharmacokinetics to guide optimal first-in-human study design (Q34223916) (← links)
• Pharmacokinetics/Pharmacodynamics and the stages of drug development: role of modeling and simulation (Q36341664) (← links)
• A d-optimal designed population pharmacokinetic study of oral itraconazole in adult cystic fibrosis patients (Q36388027) (← links)
• Facilitation of drug evaluation in children by population methods and modelling (Q37108169) (← links)
• Simultaneous population optimal design for pharmacokinetic-pharmacodynamic experiments (Q37361446) (← links)
• Penetration of antibacterials into bone: pharmacokinetic, pharmacodynamic and bioanalytical considerations (Q37409468) (← links)
• Development of a sufficient design for estimation of fluconazole pharmacokinetics in people with HIV infection. (Q43112879) (← links)
• Simultaneous optimal experimental design for in vitro binding parameter estimation (Q44771007) (← links)
• Simultaneous optimal experimental design on dose and sample times (Q46075838) (← links)
• Drug-drug interaction predictions with PBPK models and optimal multiresponse sampling time designs: application to midazolam and a phase I compound. Part 1: comparison of uniresponse and multiresponse designs using PopDes (Q46171420) (← links)
• Adaptive-optimal design in PET occupancy studies (Q48260461) (← links)
• An effective approach for obtaining optimal sampling windows for population pharmacokinetic experiments (Q51857180) (← links)
• Optimal blood sampling time windows for parameter estimation using a population approach: design of a phase II clinical trial (Q51958556) (← links)
• Optimization of individual and population designs using Splus. (Q52002156) (← links)
• Further Developments of the Fisher Information Matrix in Nonlinear Mixed Effects Models with Evaluation in Population Pharmacokinetics (Q52017271) (← links)
• The use of simulated annealing for finding optimal population designs. (Q52037656) (← links)
• Optimal dynamic control approach in a multi-objective therapeutic scenario: Application to drug delivery in the treatment of prostate cancer. (Q52315631) (← links)
• Evaluation of the Pre-Posterior Distribution of Optimized Sampling Times for the Design of Pharmacokinetic Studies (Q56994298) (← links)
• Some Considerations on the Design of Population Pharmacokinetic Studies (Q59621184) (← links)
• Robust Population Pharmacokinetic Experiment Design (Q59752794) (← links)